Numbers Reversed. In the Original Contribution entitled "Cardiovascular Disease Outcomes
During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement
Study Follow-up (HERS II)" published in the July 3, 2002, issue of THE JOURNAL
(2002;288:49-57), 2 numbers were reversed. On page 53, the fourth sentence
in the "Adjusted and per Protocol Analyses" section should read "By the end
of follow-up in HERS II, the proportion of statin use was 63% for the hormone
group and 67% for the placebo group (P = .01)."